Jean-Marc Bellemin
Financieel Directeur/CFO bij IOVANCE BIOTHERAPEUTICS, INC.
Vermogen: 675 967 $ op 30-04-2024
Actieve functies van Jean-Marc Bellemin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 11-03-2021 | - |
| Financieel Directeur/CFO | 14-12-2020 | - | |
| Treasurer | 14-12-2020 | - |
Loopbaan van Jean-Marc Bellemin
Eerdere bekende functies van Jean-Marc Bellemin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GRITSTONE BIO, INC. | Financieel Directeur/CFO | 01-01-2018 | 11-12-2020 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01-01-2008 | 01-12-2017 |
Opleiding van Jean-Marc Bellemin
| Université Paris Dauphine-PSL | Undergraduate Degree |
| Université Paris II Panthéon Assas | Graduate Degree |
| ESSEC Business School | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Frankrijk | 4 |
Operationeel
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GRITSTONE BIO, INC. | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Beurs
- Insiders
- Jean-Marc Bellemin
- Ervaring
